Actinogen Medical Limited
ATGGF
$0.03
$0.000.00%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -11.60M | -10.53M | -9.56M | -7.95M | -6.38M |
| Total Depreciation and Amortization | 277.30K | 274.20K | 273.20K | 270.30K | 268.80K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -2.46M | -617.70K | 1.32M | 2.72M | 4.07M |
| Change in Net Operating Assets | 3.22M | 3.22M | 3.22M | -255.50K | -3.70M |
| Cash from Operations | -10.56M | -7.65M | -4.74M | -5.21M | -5.74M |
| Capital Expenditure | -24.40K | -24.30K | -24.20K | -15.00K | -6.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -24.40K | -24.30K | -24.20K | -15.00K | -6.00K |
| Total Debt Issued | 3.00M | 3.00M | 3.00M | 1.50M | -- |
| Total Debt Repaid | -3.22M | -1.64M | -60.60K | -69.70K | -78.80K |
| Issuance of Common Stock | 331.60K | 6.28M | 12.24M | 16.79M | 21.34M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | -264.90K | -529.80K | -835.00K | -1.14M |
| Cash from Financing | 13.10K | 4.75M | 9.60M | 11.43M | 13.28M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -10.57M | -2.92M | 4.83M | 6.20M | 7.53M |